TDV Clinical Trials
2 recruitingBiologic
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
Dengue Fever
Takeda800 enrolled7 locationsNCT06579755
Recruiting
Phase 3
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
Dengue Fever
Takeda212 enrolled4 locationsNCT06665035